PROSTATE CANCER SCREENING
Clinical trials for PROSTATE CANCER SCREENING explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER SCREENING trials appear
Sign up with your email to follow new studies for PROSTATE CANCER SCREENING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smarter prostate cancer screening: a blood test that may cut unnecessary biopsies
Diagnosis OngoingThis study is testing whether a new blood test called ClarityDX Prostate can better identify men who have clinically significant prostate cancer. The test is given to men aged 40-75 with elevated PSA levels (3 ng/mL or higher) who are already scheduled for a prostate biopsy. Rese…
Matched conditions: PROSTATE CANCER SCREENING
Sponsor: Nanostics • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC
-
Smarter prostate screening: a new risk score aims to cut unnecessary biopsies
Diagnosis ENROLLING_BY_INVITATIONThis trial is testing whether a blood-based risk score called ClarityDX Prostate can help doctors decide which men truly need an MRI or biopsy when checking for prostate cancer. The test combines standard PSA levels with age and other factors to give a personalized risk estimate.…
Matched conditions: PROSTATE CANCER SCREENING
Phase: NA • Sponsor: Nanostics • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC